Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)

Name: Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)
Brand: KMD Bioscience
SKU: YR1164

YR1164

科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab

DATASHEET MSDS

Product Description

Alias	科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab
Catalog Number	YR1164
Molecular Name	Bapineuzumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1
Formulation	PBS, pH7.5
Background	Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF.
CAS Number	648895-38-9
Application	WB, FuncS, IF, Neut, ELISA, FCM, IP
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	APP Abeta[Homo sapiens]

Login